In the last 12 months, insiders at Cardio Diagnostics Holdings, Inc. ($CDIO) filed 126 transactions with the SEC: 18 open-market purchases totaling $170,086 and 0 sales totaling $0. Net insider sentiment: net buying.
Cardio Diagnostics Holdings, Inc. operates in the In vitro & in vivo diagnostic substances industry (Life sciences sector).
Most Active Insiders
- Levy Oded (Director) — 16 transactions totaling $87,500
- Lau Stanley K. (Director) — 25 transactions totaling $86,498
- Intrater James (Director) — 20 transactions totaling $75,014
- Dogan Meeshanthini (Chief Executive Officer) — 10 transactions totaling $69,972
- Sim Brandon (Director) — 9 transactions totaling $62,500
View all SEC Filings for Cardio Diagnostics Holdings, Inc. (CDIO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Fung Peter K | Director | A | Stock Options (Right to Buy) | 3205 | $1.95 | 9,513.0000 | 1,826,051 | 50.81% | 0.18% |
| March 31, 2026 | Betts Wendy J | Director | A | Stock Options (Right to Buy) | 3205 | $1.95 | 9,513.0000 | 1,826,051 | 50.81% | 0.18% |
| March 31, 2026 | Intrater James | Director | A | Stock Options (Right to Buy) | 3205 | $1.95 | 10,464.0000 | 1,826,051 | 44.15% | 0.18% |
| March 31, 2026 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 3205 | $1.95 | 10,464.0000 | 1,826,051 | 44.15% | 0.18% |
| Dec. 31, 2025 | Betts Wendy J | Director | A | Stock Options (Right to Buy) | 2306 | $2.71 | 6,308.0000 | 1,826,051 | 57.62% | 0.13% |
| Dec. 31, 2025 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 2306 | $2.71 | 7,259.0000 | 1,826,051 | 46.56% | 0.13% |
| Dec. 31, 2025 | Intrater James | Director | A | Stock Options (Right to Buy) | 2306 | $2.71 | 7,259.0000 | 1,826,051 | 46.56% | 0.13% |
| Dec. 31, 2025 | Fung Peter K | Director | A | Stock Options (Right to Buy) | 2306 | $2.71 | 6,308.0000 | 1,826,051 | 57.62% | 0.13% |
| Sept. 30, 2025 | Intrater James | Director | A | Stock Options (Right to Buy) | 1559 | $4.01 | 4,953.0000 | 52,145,416 | 45.93% | 0.00% |
| Sept. 30, 2025 | Fung Peter K | Director | A | Stock Options (Right to Buy) | 1559 | $4.01 | 4,002.0000 | 52,145,416 | 63.81% | 0.00% |
| Sept. 30, 2025 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 1559 | $4.01 | 4,953.0000 | 52,145,416 | 45.93% | 0.00% |
| Sept. 30, 2025 | Betts Wendy J | Director | A | Stock Options (Right to Buy) | 1559 | $4.01 | 4,002.0000 | 52,145,416 | 63.81% | 0.00% |
| June 30, 2025 | Betts Wendy J | Director | A | Stock Options (Right to Buy) | 1736 | $3.60 | 2,443.0000 | 52,145,416 | 245.54% | 0.00% |
| June 30, 2025 | Fung Peter K | Director | A | Stock Options (Right to Buy) | 1736 | $3.60 | 2,443.0000 | 52,145,416 | 245.54% | 0.00% |
| June 30, 2025 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 1736 | $3.60 | 3,394.0000 | 52,145,416 | 104.70% | 0.00% |
| June 30, 2025 | Intrater James | Director | A | Stock Options (Right to Buy) | 1736 | $3.60 | 3,394.0000 | 52,145,416 | 104.70% | 0.00% |
| March 31, 2025 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 18939 | $0.33 | 49,744.0000 | 52,145,416 | 61.48% | 0.04% |
| March 31, 2025 | Intrater James | Director | A | Stock Options (Right to Buy) | 18939 | $0.33 | 49,744.0000 | 52,145,416 | 61.48% | 0.04% |
| March 31, 2025 | Fung Peter K | Director | A | Stock Options (Right to Buy) | 18939 | $0.33 | 21,211.0000 | 52,145,416 | 833.58% | 0.04% |
| March 31, 2025 | Betts Wendy J | Director | A | Stock Options (Right to Buy) | 18939 | $0.33 | 21,211.0000 | 52,145,416 | 833.58% | 0.04% |
| Dec. 31, 2024 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 4544 | $0.92 | 30,805.0000 | 0 | 17.30% | 0.00% |
| Dec. 31, 2024 | Intrater James | Director | A | Stock Options (Right to Buy) | 4544 | $0.92 | 30,805.0000 | 0 | 17.30% | 0.00% |
| Sept. 30, 2024 | Levy Oded | Director | A | Stock Options (Right to Buy) | 18686 | $0.22 | 26,261.0000 | 0 | 246.68% | 0.00% |
| Sept. 30, 2024 | Lau Stanley K. | Director | A | Stock Options (Right to Buy) | 18686 | $0.22 | 26,261.0000 | 0 | 246.68% | 0.00% |
| Sept. 30, 2024 | Intrater James | Director | A | Stock Options (Right to Buy) | 18686 | $0.22 | 26,261.0000 | 0 | 246.68% | 0.00% |
| Sept. 30, 2024 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 18686 | $0.22 | 26,261.0000 | 0 | 246.68% | 0.00% |
| Sept. 6, 2024 | Dogan Timur | Chief Technology Officer | P | Common Stock | 68965 | $0.29 | 197,310.0000 | 0 | 53.73% | 0.00% |
| Sept. 6, 2024 | Dogan Meeshanthini | Chief Executive Officer | P | Common Stock | 68965 | $0.29 | 1,655,429.0000 | 0 | 4.35% | 0.00% |
| Sept. 6, 2024 | Dogan Meeshanthini | Chief Executive Officer | P | Common Stock | 68965 | $0.29 | 1,655,429.0000 | 0 | 4.35% | 0.00% |
| Sept. 6, 2024 | Dogan Timur | Chief Technology Officer | P | Common Stock | 68965 | $0.29 | 197,310.0000 | 0 | 53.73% | 0.00% |
| Sept. 6, 2024 | Philibert Robert | Chief Medical Officer | P | Common Stock | 7460 | $0.28 | 1,683,867.0000 | 0 | 0.44% | 0.00% |
| Sept. 6, 2024 | Philibert Robert | Chief Medical Officer | P | Common Stock | 26615 | $0.29 | 1,676,407.0000 | 0 | 1.61% | 0.00% |
| Sept. 6, 2024 | Dogan Meeshanthini | Chief Executive Officer | P | Common Stock | 68965 | $0.29 | 1,683,867.0000 | 0 | 4.27% | 0.00% |
| Sept. 6, 2024 | Dogan Meeshanthini | Chief Technology Officer | P | Common Stock | 68965 | $0.29 | 197,310.0000 | 0 | 53.73% | 0.00% |
| June 30, 2024 | Lau Stanley K. | Director | A | Stock Options (Right to Buy) | 7575 | $0.55 | 7,575.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2024 | Burton Paul Frederick | Director | A | Stock Options (Right to Buy) | 7575 | $0.55 | 7,575.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2024 | Intrater James | Director | A | Stock Options (Right to Buy) | 7575 | $0.55 | 7,575.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2024 | Levy Oded | Director | A | Stock Options (Right to Buy) | 7575 | $0.55 | 7,575.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2024 | Levy Oded | Director | M | Restricted Stock Units | 12500 | $0.00 | 37,500.0000 | 0 | 25.00% | 0.00% |
| March 31, 2024 | Burton Paul Frederick | Director | M | Common Stock | 8803 | $1.42 | 8,803.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2024 | Burton Paul Frederick | Director | M | Restricted Stock Units | 12500 | $0.00 | 37,500.0000 | 0 | 50.00% | 0.00% |
| March 31, 2024 | Lau Stanley K. | Director | M | Common Stock | 8803 | $1.42 | 100,325.0000 | 0 | 9.62% | 0.00% |
| March 31, 2024 | Lau Stanley K. | Director | M | Restricted Stock Units | 12500 | $0.00 | 37,400.0000 | 0 | 50.20% | 0.00% |
| March 31, 2024 | Intrater James | Director | M | Common Stock | 8803 | $1.42 | 71,596.0000 | 0 | 14.02% | 0.00% |
| March 31, 2024 | Intrater James | Director | M | Restricted Stock Units | 12500 | $0.00 | 37,500.0000 | 0 | 50.00% | 0.00% |
| March 31, 2024 | Levy Oded | Director | M | Common Stock | 8803 | $1.42 | 71,596.0000 | 0 | 14.02% | 0.00% |
| Jan. 23, 2024 | Lau Stanley K. | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Dogan Meeshanthini | Chief Executive Officer | A | Stock Options (Right to Buy) | 238128 | $2.11 | 1,869,425.0000 | 0 | 14.60% | 0.00% |
| Jan. 23, 2024 | Dogan Meeshanthini | Chief Executive Officer | A | Stock Options (Right to Buy) | 476256 | $2.11 | 1,869,425.0000 | 0 | 34.19% | 0.00% |
| Jan. 23, 2024 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 476256 | $2.11 | 1,869,425.0000 | 0 | 34.19% | 0.00% |
| Jan. 23, 2024 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 238128 | $2.11 | 1,869,425.0000 | 0 | 14.60% | 0.00% |
| Jan. 23, 2024 | Hosseinion Warren | Director | A | Stock Options (Right to Buy) | 35719 | $2.11 | 502,195.0000 | 0 | 7.66% | 0.00% |
| Jan. 23, 2024 | Philibert Robert | Chief Medical Officer | A | Stock Options (Right to Buy) | 142876 | $2.11 | 805,465.0000 | 0 | 21.56% | 0.00% |
| Jan. 23, 2024 | Abdullahi Khullani | VP of Revenue and Strategy | A | Stock Options (Right to Buy) | 238128 | $2.11 | 304,128.0000 | 0 | 360.80% | 0.00% |
| Jan. 23, 2024 | Luqman Elisa V | Chief Financial Officer | A | Stock Options (Right to Buy) | 35719 | $2.11 | 264,832.0000 | 0 | 15.59% | 0.00% |
| Jan. 23, 2024 | Levy Oded | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Burton Paul Frederick | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Intrater James | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Lau Stanley K. | Director | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 31, 2024 | Lau Stanley K. | Director | M | Common Stock | 917 | $2.18 | 91,522.0000 | 0 | 1.01% | 0.00% |
| Dec. 31, 2023 | Intrater James | Director | M | Common Stock | 5020 | $2.49 | 62,793.0000 | 0 | 8.69% | 0.00% |
| Dec. 31, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Levy Oded | Director | M | Common Stock | 5020 | $2.49 | 62,793.0000 | 0 | 8.69% | 0.00% |
| Dec. 31, 2023 | Levy Oded | Director | M | Restricted Stock Units | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Levy Oded | Director | P | Restricted Stock Units | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Sim Brandon | Director | M | Common Stock | 5020 | $2.49 | 62,793.0000 | 0 | 8.69% | 0.00% |
| Dec. 31, 2023 | Sim Brandon | Director | M | Restricted Stock Units | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Levy Oded | Director | M | Common Stock | 5020 | $2.49 | 62,793.0000 | 0 | 8.69% | 0.00% |
| Dec. 31, 2023 | Intrater James | Director | M | Restricted Stock Units | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Lau Stanley K. | Director | M | Common Stock | 1606 | $2.49 | 85,585.0000 | 0 | 1.91% | 0.00% |
| Dec. 31, 2023 | Lau Stanley K. | Director | M | Common Stock | 5020 | $2.49 | 90,605.0000 | 0 | 5.87% | 0.00% |
| Dec. 31, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 4000 | $0.00 | 2,000.0000 | 0 | 66.67% | 0.00% |
| Oct. 31, 2023 | Lau Stanley K. | Director | M | Common Stock | 6631 | $0.30 | 83,979.0000 | 0 | 8.57% | 0.00% |
| June 23, 2023 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 156750 | $1.26 | 429,000.0000 | 0 | 57.58% | 0.00% |
| June 23, 2023 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 272250 | $1.26 | 429,000.0000 | 0 | 173.68% | 0.00% |
| Aug. 31, 2023 | Lau Stanley K. | Director | M | Common Stock | 3637 | $0.55 | 34,701.0000 | 0 | 11.71% | 0.00% |
| July 31, 2023 | Lau Stanley K. | Director | M | Common Stock | 1653 | $1.21 | 31,064.0000 | 0 | 5.62% | 0.00% |
| Sept. 30, 2023 | Lau Stanley K. | Director | M | Common Stock | 5882 | $0.34 | 40,583.0000 | 0 | 16.95% | 0.00% |
| Sept. 30, 2023 | Lau Stanley K. | Director | M | Common Stock | 36765 | $0.34 | 77,348.0000 | 0 | 90.59% | 0.00% |
| July 31, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 2000 | $0.00 | 12,000.0000 | 0 | 14.29% | 0.00% |
| Aug. 31, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 2000 | $0.00 | 10,000.0000 | 0 | 16.67% | 0.00% |
| Sept. 30, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 2000 | $0.00 | 8,000.0000 | 0 | 20.00% | 0.00% |
| Sept. 30, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 50.00% | 0.00% |
| Sept. 30, 2023 | Levy Oded | Director | M | Common Stock | 36765 | $0.34 | 57,773.0000 | 0 | 175.00% | 0.00% |
| Sept. 30, 2023 | Levy Oded | Director | P | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 50.00% | 0.00% |
| Sept. 30, 2023 | Intrater James | Director | M | Common Stock | 36765 | $0.34 | 57,773.0000 | 0 | 175.00% | 0.00% |
| Sept. 30, 2023 | Intrater James | Director | P | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 50.00% | 0.00% |
| Sept. 30, 2023 | Sim Brandon | Director | M | Common Stock | 36765 | $0.34 | 57,773.0000 | 0 | 175.00% | 0.00% |
| Sept. 30, 2023 | Sim Brandon | Director | M | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 50.00% | 0.00% |
| Sept. 30, 2023 | Intrater James | Director | M | Common Stock | 36765 | $0.34 | 57,773.0000 | 0 | 175.00% | 0.00% |
| Sept. 30, 2023 | Levy Oded | Director | M | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2023 | Levy Oded | Director | M | Common Stock | 36765 | $0.34 | 57,773.0000 | 0 | 175.00% | 0.00% |
| Sept. 30, 2023 | Sim Brandon | Director | M | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2023 | Sim Brandon | Director | M | Common Stock | 36765 | $0.34 | 57,773.0000 | 0 | 175.00% | 0.00% |
| Sept. 30, 2023 | Intrater James | Director | M | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 25, 2023 | Dogan Timur | Chief Technology Officer | P | Common Stock | 1770 | $0.56 | 111,864.0000 | 0 | 1.61% | 0.00% |
| Aug. 31, 2023 | Dogan Timur | Chief Technology Officer | P | Common Stock | 16481 | $0.55 | 128,345.0000 | 0 | 14.73% | 0.00% |
| Aug. 31, 2023 | Dogan Meeshanthini | Chief Executive Officer | P | Common Stock | 16481 | $0.55 | 128,345.0000 | 0 | 14.73% | 0.00% |
| Aug. 25, 2023 | Dogan Meeshanthini | Chief Executive Officer | P | Common Stock | 1770 | $0.56 | 111,864.0000 | 0 | 1.61% | 0.00% |
| Aug. 24, 2023 | Philibert Robert | Chief Medical Officer | P | Common Stock | 16000 | $0.60 | 3,281,584.0000 | 0 | 0.49% | 0.00% |
| Aug. 28, 2023 | Philibert Robert | Chief Medical Officer | P | Common Stock | 17900 | $0.60 | 3,281,484.0000 | 0 | 0.55% | 0.00% |
| Aug. 28, 2023 | Philibert Robert | Chief Medical Officer | P | Common Stock | 100 | $0.57 | 3,281,584.0000 | 0 | 0.00% | 0.00% |
| June 30, 2023 | Levy Oded | Director | M | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 14000 | $0.00 | 39,000.0000 | 0 | 56.00% | 0.00% |
| June 30, 2023 | Lau Stanley K. | Director | M | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2023 | Lau Stanley K. | Director | M | Common Stock | 8403 | $1.19 | 29,411.0000 | 0 | 40.00% | 0.00% |
| June 30, 2023 | Lau Stanley K. | Director | M | Common Stock | 21008 | $1.19 | 21,008.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Intrater James | Director | M | Common Stock | 21008 | $1.19 | 21,208.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Intrater James | Director | M | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Sim Brandon | Director | M | Common Stock | 21008 | $1.19 | 21,008.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Sim Brandon | Director | M | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Levy Oded | Director | M | Common Stock | 21008 | $1.19 | 21,008.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 272250 | $1.26 | 430,000.0000 | 0 | 172.58% | 0.00% |
| June 23, 2023 | Dogan Meeshanthini | Chief Executive Officer | A | Stock Options (Right to Buy) | 157570 | $1.26 | 430,000.0000 | 0 | 57.84% | 0.00% |
| June 23, 2023 | Dogan Meeshanthini | Chief Executive Officer | A | Stock Options (Right to Buy) | 272250 | $1.26 | 430,000.0000 | 0 | 172.58% | 0.00% |
| June 23, 2023 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 157750 | $1.26 | 430,000.0000 | 0 | 57.94% | 0.00% |
| June 23, 2023 | Abdullahi Khullani | VP of Revenue and Strategy | A | Stock Options (Right to Buy) | 66000 | $1.26 | 66,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Dogan Timur | Chief Technology Officer | A | Stock Options (Right to Buy) | 156750 | $1.26 | 156,750.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Dogan Meeshanthini | Chief Executive Officer | A | Stock Options (Right to Buy) | 272250 | $1.26 | 272,250.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Hosseinion Warren | Director | A | Stock Options (Right to Buy) | 123750 | $1.26 | 123,750.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Philibert Robert | Chief Medical Officer | A | Stock Options (Right to Buy) | 148500 | $1.26 | 148,500.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Luqman Elisa V | Chief Financial Officer | A | Stock Options (Right to Buy) | 57750 | $1.26 | 57,750.0000 | 0 | 9999.99% | 0.00% |
| June 19, 2023 | Lau Stanley K. | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 19, 2023 | Intrater James | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 19, 2023 | Sim Brandon | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 19, 2023 | Levy Oded | Director | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |